![Metabolites | Free Full-Text | Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver Disease Metabolites | Free Full-Text | Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver Disease](https://www.mdpi.com/metabolites/metabolites-12-00440/article_deploy/html/images/metabolites-12-00440-g001.png)
Metabolites | Free Full-Text | Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver Disease
![Correction: Tyrosine bioconjugation – an emergent alternative - Organic & Biomolecular Chemistry (RSC Publishing) DOI:10.1039/D2OB90141B Correction: Tyrosine bioconjugation – an emergent alternative - Organic & Biomolecular Chemistry (RSC Publishing) DOI:10.1039/D2OB90141B](https://pubs.rsc.org/image/article/2022/OB/d2ob90141b/d2ob90141b-s7_hi-res.gif)
Correction: Tyrosine bioconjugation – an emergent alternative - Organic & Biomolecular Chemistry (RSC Publishing) DOI:10.1039/D2OB90141B
![Enhanced tyrosine hydroxylase activity induces oxidative stress, causes accumulation of autotoxic catecholamine metabolites, and augments amphetamine effects in vivo - Vecchio - 2021 - Journal of Neurochemistry - Wiley Online Library Enhanced tyrosine hydroxylase activity induces oxidative stress, causes accumulation of autotoxic catecholamine metabolites, and augments amphetamine effects in vivo - Vecchio - 2021 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/8b192872-a8e0-4aeb-a8c7-c5e07a973284/jnc15432-fig-0007-m.jpg)
Enhanced tyrosine hydroxylase activity induces oxidative stress, causes accumulation of autotoxic catecholamine metabolites, and augments amphetamine effects in vivo - Vecchio - 2021 - Journal of Neurochemistry - Wiley Online Library
![Author Correction: Eosinophil differentiation in the bone marrow is promoted by protein tyrosine phosphatase SHP2 | Cell Death & Differentiation Author Correction: Eosinophil differentiation in the bone marrow is promoted by protein tyrosine phosphatase SHP2 | Cell Death & Differentiation](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41418-018-0247-8/MediaObjects/41418_2018_247_Fig1_HTML.png)
Author Correction: Eosinophil differentiation in the bone marrow is promoted by protein tyrosine phosphatase SHP2 | Cell Death & Differentiation
![Correction to: Quantitative phosphoproteomic analysis reveals reciprocal activation of receptor tyrosine kinases between cancer epithelial cells and stromal fibroblasts | Clinical Proteomics | Full Text Correction to: Quantitative phosphoproteomic analysis reveals reciprocal activation of receptor tyrosine kinases between cancer epithelial cells and stromal fibroblasts | Clinical Proteomics | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12014-018-9210-4/MediaObjects/12014_2018_9210_Fig3_HTML.png)
Correction to: Quantitative phosphoproteomic analysis reveals reciprocal activation of receptor tyrosine kinases between cancer epithelial cells and stromal fibroblasts | Clinical Proteomics | Full Text
![Correction to: Population Pharmacokinetics of Asciminib in Tyrosine Kinase Inhibitor-Treated Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic and Acute Phases | SpringerLink Correction to: Population Pharmacokinetics of Asciminib in Tyrosine Kinase Inhibitor-Treated Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic and Acute Phases | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40262-022-01166-7/MediaObjects/40262_2022_1166_Fig1_HTML.png)
Correction to: Population Pharmacokinetics of Asciminib in Tyrosine Kinase Inhibitor-Treated Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic and Acute Phases | SpringerLink
![Author Correction: NRF2-GPX4/SOD2 axis imparts resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer cells | Acta Pharmacologica Sinica Author Correction: NRF2-GPX4/SOD2 axis imparts resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer cells | Acta Pharmacologica Sinica](https://media.springernature.com/lw703/springer-static/image/art%3A10.1038%2Fs41401-023-01131-5/MediaObjects/41401_2023_1131_Figa_HTML.png)
Author Correction: NRF2-GPX4/SOD2 axis imparts resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer cells | Acta Pharmacologica Sinica
Correction: Analysis of Tyrosine Kinase Inhibitor-Mediated Decline in Contractile Force in Rat Engineered Heart Tissue | PLOS ONE
![QCM annales chimie organique LAS 2020-2021 - PROFILSUP - PREPA P0 – profilsup – Tous droits - Studocu QCM annales chimie organique LAS 2020-2021 - PROFILSUP - PREPA P0 – profilsup – Tous droits - Studocu](https://d20ohkaloyme4g.cloudfront.net/img/document_thumbnails/24e3b7a5cc3543b760490783dc08c66b/thumb_1200_1697.png)